Integral Health Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Integral Health Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,000	Closed	-$2.78M	–	92
2021 Q3	$2.78M	Buy	+20,000	New	+$2.5M	0.8%	48
2021 Q1	–	Sell	-15,000	Closed	-$1.29M	–	88
2020 Q4	$1.29M	Buy	+15,000	New	+$1.27M	0.38%	54

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Integral Health Asset Management's BHVN Position: Q4 2021 in Review

Integral Health Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2021, closing a stake of 20,000 shares — an estimated $2.78M sold.

Integral Health Asset Management first reported a position in BHVN in Q4 2020 and held it in 2 quarters. The position peaked at $2.78M in Q3 2021. 284 funds tracked by Wall St. Rank hold BHVN as of Q4 2021.

Integral Health Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2021 after selling out during the quarter.
Integral Health Asset Management sold 20,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2021, an estimated $2.78M.
Integral Health Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020 and held it in 2 quarters.
Integral Health Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.78M in Q3 2021.
284 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2021.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.